Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings

C. Jonsson-Oldenbuettel; J. Ghosn; M. van der Valk; E. Florence; F. Vera; M. Ait-Khaled; G. Bontempo; C. Latham; C. A. Gutner; S. Iyer; R. DeMoor; M. Gill; M. Czarnogorski; J. van Wyk

doi:10.1002/jia2.25935

Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings

C. Jonsson-Oldenbuettel
, J. Ghosn
, M. van der Valk
, E. Florence
, F. Vera
, M. Ait-Khaled
, G. Bontempo
, C. Latham
, C. A. Gutner
, S. Iyer
, R. DeMoor
, M. Gill
, M. Czarnogorski
, J. van Wyk

Research output: Contribution to journal › Meeting abstract in journal

Original language	English
Article number	EPLBB05
Journal	Journal of the International AIDS Society
Volume	25
Issue number	S3
Pages (from-to)	241-242
Number of pages	2
ISSN	1758-2652
DOIs	https://doi.org/10.1002/jia2.25935
Publication status	Published - 2022

Access to Document

10.1002/jia2.25935Licence: CC BY

Cite this

Jonsson-Oldenbuettel, C., Ghosn, J., van der Valk, M., Florence, E., Vera, F., Ait-Khaled, M., Bontempo, G., Latham, C., Gutner, C. A., Iyer, S., DeMoor, R., Gill, M., Czarnogorski, M., & van Wyk, J. (2022). Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings. Journal of the International AIDS Society, 25(S3), 241-242. Article EPLBB05. https://doi.org/10.1002/jia2.25935

@article{35a89d3ad7804572ab8abc552b8e1067,

title = "Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings",

author = "C. Jonsson-Oldenbuettel and J. Ghosn and \{van der Valk\}, M. and E. Florence and F. Vera and M. Ait-Khaled and G. Bontempo and C. Latham and Gutner, \{C. A.\} and S. Iyer and R. DeMoor and M. Gill and M. Czarnogorski and \{van Wyk\}, J.",

note = "FTX: CC BY ",

year = "2022",

doi = "10.1002/jia2.25935",

language = "English",

volume = "25",

pages = "241--242",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "John Wiley \& Sons",

number = "S3",

}

Jonsson-Oldenbuettel, C, Ghosn, J, van der Valk, M, Florence, E, Vera, F, Ait-Khaled, M, Bontempo, G, Latham, C, Gutner, CA, Iyer, S, DeMoor, R, Gill, M, Czarnogorski, M & van Wyk, J 2022, 'Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings', Journal of the International AIDS Society, vol. 25, no. S3, EPLBB05, pp. 241-242. https://doi.org/10.1002/jia2.25935

Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings. / Jonsson-Oldenbuettel, C.; Ghosn, J.; van der Valk, M. et al.
In: Journal of the International AIDS Society, Vol. 25, No. S3, EPLBB05, 2022, p. 241-242.

Research output: Contribution to journal › Meeting abstract in journal

TY - JOUR

T1 - Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings

AU - Jonsson-Oldenbuettel, C.

AU - Ghosn, J.

AU - van der Valk, M.

AU - Florence, E.

AU - Vera, F.

AU - Ait-Khaled, M.

AU - Bontempo, G.

AU - Latham, C.

AU - Gutner, C. A.

AU - Iyer, S.

AU - DeMoor, R.

AU - Gill, M.

AU - Czarnogorski, M.

AU - van Wyk, J.

N1 - FTX: CC BY

PY - 2022

Y1 - 2022

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000834867400456

U2 - 10.1002/jia2.25935

DO - 10.1002/jia2.25935

M3 - Meeting abstract in journal

SN - 1758-2652

VL - 25

SP - 241

EP - 242

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

IS - S3

M1 - EPLBB05

ER -

Safety and effectiveness outcomes from the Carisel study: phase 3b hybrid-3 implementation study integrating cabotegravir plus rilpivirine long-acting into European clinical settings

Access to Document

Other files and links

Cite this